Table 2 Comparison of pre- and post-surgical serum AMH concentrations between pre-surgical adverse DOR and non-DOR patients with ovarian endometriomas
AMH (ng/ml) | p value | ||
|---|---|---|---|
Adverse DOR (n = 31) | Non-DOR (n = 112) | ||
Presurgical | 0.7 ± 0.3 (0.6–0.8) | 4.0 ± 2.8 (3.5–4.5) | <0.001 |
3 months after surgery | 0.4 ± 0.4 (0.3–0.6) | 2.3 ± 2.2 (1.9–2.8) | <0.001 |
6 months after surgery | 0.5 ± 0.4 (0.4–0.7) | 2.3 ± 2.1 (1.9–2.7) | <0.001 |